 |
|
|
 |
Researchers Find Evidence That Prenatal Use of Ecstasy Can Cause Long-Term Memory Loss And Other Impairments In Offspring
Researchers today reported the first evidence that a mother's use of MDMA (ecstasy) during pregnancy may result in specific types of long-term learning and memory impairments in her offspring. The research, published in the May 1, 2001, issue of the Journal of Neuroscience, was conducted by scientists from Children's Hospital Research Foundation and the University of Cincinnati College of Medicine. The researchers administered MDMA to two groups of newborn rats. One group received ecstasy twice a day for 10 days after birth (analogous to early third-trimester brain development in humans); the other group received ecstasy twice a day during days 11 through 20 (analogous to late human third-trimester brain development). more
|
|
Beta-Blocking Agent Demonstrates Benefit In African-Americans With Heart Failure
A retrospective analysis published this week in the New England Journal of Medicine demonstrated that Coreg (carvedilol) reduced the risk of death or hospitalization from heart failure in black patients to the same extent as in non-black patients. Carvedilol may be the first beta-blocking agent to show a benefit in this patient population. These findings are significant because previous studies with beta-blocking agents and ACE inhibitors in heart failure have indicated that black patients derive less benefit from these classes of drugs. more
|
|
|
|
Vagus Nerve Stimulation (VNS) Has Positive Effect On Sleep Disturbances In Depressed Patients
Results of a preliminary study show vagus nerve stimulation (VNS) therapy may effectively normalize sleep abnormalities in depressed patients. Results of the study, led by Dr. Roseanne Armitage of the University of Texas Southwestern, will be presented at the upcoming annual meetings of the American Academy of Neurology, the American Psychiatric Association and the Society of Biological Psychiatry. more
|
|
US National Strategy for Suicide Prevention: Goals and Objectives for Action (NSSP or National Strategy)
Only recently have the knowledge and tools become available to approach suicide as a preventable problem with realistic opportunities to save many lives. The Surgeon General's "US National Strategy for Suicide Prevention: Goals and Objectives for Action (NSSP or National Strategy)" is designed to be a catalyst for social change, with the power to transform attitudes, policies, and services. It reflects a comprehensive and integrated approach to reducing the loss and suffering from suicide and suicidal behaviors in the United States. The effective implementation of the "National Strategy" will play a critical role in reaching the suicide prevention goals outlined in the US national public health agenda. Get the full Surgeon General report in today's issue of Vidyya. more
|
|
WHO And Aventis Will Work To Eradicate African Trypanosomiasis (Sleeping Sickness)
The World Health Organization (WHO) and Aventis Pharma AG, today announced a major step forward in combating African Trypanosomiasis. Better known as sleeping sickness, this deadly disease currently affects as many as half a million people in sub-Saharan Africa, while an estimated 60 million people are at risk of contracting the disease in 36 countries. more
|
|
|
